IGM Biosciences, Inc. operates as a biotechnology company. The Company specializes in the research and development for the treatment of cancer. IGM Biosciences serves customers in the United States.

Current Report (Form 8-K | Period ending 2025-08-14)

Quarterly Report (Form 10-Q | Period ending 2025-06-30)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

IGM Biosciences Inc (IGMS US)

Current Report (Form 8-K | Period ending 2025-08-14)

Quarterly Report (Form 10-Q | Period ending 2025-06-30)

SC14D9C | Written communication by the subject company relating to a third party tender offer

Current Report (Form 8-K | Period ending 2025-07-01)

Current Report (Form 8-K | Period ending 2025-06-06)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)